SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-062514
Filing Date
2013-08-12
Accepted
2013-08-12 07:02:22
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-16335_110q.htm 10-Q 918755
2 EX-10.1 a13-16335_1ex10d1.htm EX-10.1 68067
3 EX-31.1 a13-16335_1ex31d1.htm EX-31.1 11635
4 EX-32.1 a13-16335_1ex32d1.htm EX-32.1 5604
  Complete submission text file 0001104659-13-062514.txt   7643057

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20130630.xml EX-101.INS 574756
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20130630.xsd EX-101.SCH 34591
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20130630_cal.xml EX-101.CAL 41371
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20130630_def.xml EX-101.DEF 219862
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20130630_lab.xml EX-101.LAB 573838
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20130630_pre.xml EX-101.PRE 319448
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 131028145
SIC: 2834 Pharmaceutical Preparations